---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-018383"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2023-01-30T23:59:59+00:00"
generated_at: "2026-06-20T06:33:01.297821+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MiMedx appoints ex-BioTelemetry CEO Joseph H. Capper as CEO, effective Jan 27

## Summary
- Appointed Joseph H. Capper as CEO and director, effective Jan 27, 2023; Todd Newton steps down as interim CEO but remains on board.
- Capper receives $750k salary, 100% target bonus, 3.3M PSUs (4-yr vest), and option for 3.6M shares at $3.70 strike.
- Capper previously led BioTelemetry, acquired by Philips for $2.8B; has ~30 years MedTech/Life Sciences experience.
- Inducement PSUs and option granted outside equity plan under Nasdaq Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001193125-23-018383
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2023-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/0001193125-23-018383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/d456121d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-018383
- JSON: https://secwatch.observer/filing/0001193125-23-018383.json
- Plain text: https://secwatch.observer/filing/0001193125-23-018383.txt

## Key facts
- Executive change
  K. Todd Newton departed as Interim Chief Executive Officer at MIMEDX GROUP, INC..
  - Action: stepped down
  - Role: Interim Chief Executive Officer
  source text: Also on January 30, 2023, the Company announced that K. Todd Newton will step down and cease to serve as Interim Chief Executive Officer of the Company, also effective on January 27, 2023, but will remain on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/0001193125-23-018383-index.htm
- Executive change
  Joseph H. Capper was appointed as Chief Executive Officer at MIMEDX GROUP, INC..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On January 30, 2023, MiMedx Group, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has appointed Joseph H. Capper to serve as Chief Executive Officer of the Company, effective on January 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/0001193125-23-018383-index.htm
- Executive change
  Joseph H. Capper was appointed as Director at MIMEDX GROUP, INC..
  - Action: appointed
  - Role: Director
  source text: Mr. Capper will also be appointed to the Board of Directors effective on the commencement of his employment with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/0001193125-23-018383-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.